Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Obsessive-Compulsive Disorder
Interventions: Repetitive transcranial magnetic stimulation; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Nabilone, Exposure and Response Prevention Therapy; Drug · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Stanford, California

Conditions: Anxiety Disorders, Depressive Disorders, Eating Disorders, Obsessive Compulsive Disorder
Interventions: Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications; Drug
Lead sponsor: Duke University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 569 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Healthy, Mental Disorder, Obsessive Compulsive Disorder, Schizophrenia, Tourette Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Seizures, Metabolic Encephalopathy
Interventions: Transnasal Thermal Regulating Device; Device
Lead sponsor: CoolTech LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Trichotillomania (Hair-Pulling Disorder), Skin-Picking
Interventions: self-control; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obsessive-Compulsive Disorder, Anxiety Disorders, Pediatric Disorder, Anxiety, OCD, Phobia, Agoraphobia, Generalized Anxiety, Generalized Anxiety Disorder, Selective Mutism, Separation Anxiety, Social Anxiety, Social Anxiety Disorder, Panic Disorder
Interventions: Exposure Therapy; Behavioral
Lead sponsor: Bradley Hospital; Other
Eligibility: 5 Years to 18 Years
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Riverside, Rhode Island

Conditions: Trichotillomania
Interventions: SXC-2023, Placebo; Drug
Lead sponsor: Promentis Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 13
States / cities: Pico Rivera, California • Riverside, California • North Miami, Florida + 10 more

Conditions: Parkinson Disease, Dystonia, Tremors, Obsessive Compulsive Disorder, Depression
Interventions: No intervention; Other
Lead sponsor: Ohio State University; Other
Eligibility: 7 Years to 90 Years
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obsessive Compulsive Disorder
Interventions: Luvox CR, Behavioral Therapy; Drug · Behavioral
Lead sponsor: Rogers Center for Research & Training, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Obsessive Compulsive Disorder (OCD)
Interventions: Therapist assisted mobile intervention; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Trichotillomania, Hair-Pulling Disorder
Interventions: COMB; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obsessive Compulsive Disorder, Healthy
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 145 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Social Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder, Panic Disorder, Agoraphobia, Obsessive-Compulsive Disorder
Interventions: McLean Anxiety Mastery Program; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 6 Years to 19 Years
Enrollment: 559 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: PANDAS, Anxiety Disorder, Autoimmune Diseases, Obsessive-Compulsive Disorder
Interventions: Naproxen Sodium, Placebo; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 15 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obsessive Compulsive Disorder, Body Dysmorphic Disorder, Tourette Syndrome, Trichotillomania, Panic Disorder, Social Phobia, Generalized Anxiety Disorder, Depression, Post-Traumatic Stress Disorder, Attention Deficit Hyperactivity Disorder, Eating Disorder, Specific Phobia, General Medical Condition
Interventions: Cognitive behavioral therapy (CBT); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Trichotillomania, Hair Pulling Disorder
Interventions: Milk Thistle, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 10 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Parkinson Disease, Essential Tremor, Dystonia, Obsessive Compulsive Disorder
Interventions: Functional Magnetic Resonance Imaging (fMRI); Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Trichotillomania (Hair-Pulling Disorder)
Interventions: Valbenazine Oral Capsule, Placebo Oral capsule; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obsessive-Compulsive Disorder
Interventions: Decision-Making Tasks; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anorexia Nervosa, Obsessive Compulsive Disorder, Tourette Syndrome, Trichotillomania
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hoarding Disorder, Obsessive-Compulsive Disorder
Interventions: Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST), Case Management; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 50 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Cognitive Behavioral Therapy (CBT), Relaxation Training; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 5 Years to 8 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)

Cannabinoid Medication for Adults With OCD

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

Antidepressant Safety in Kids Study

I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers

Transnasal Induction of Normothermia for Neurogenic Fever

Self-control and Body-focused Repetitive Behaviors

Improving Access to Child Anxiety Treatment

A Study in Patients With Trichotillomania

Physiological Brain Atlas Development

Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)

Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD

Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania

Cortical Excitability in Obsessive-Compulsive and Related Disorders

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS

Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals

Milk Thistle in Trichotillomania in Children and Adults

Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

Decision-making Impairments in OCD: An Integrated Behavioral Economics Model

Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions

Cognitive Rehabilitation and Exposure Therapy for Geriatric Hoarding

Family Based Treatment of Early Childhood Obsessive Compulsive Disorder